Timothy S Bailey (Timothy Bailey)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 28

Top Topics

Randomized Controlled Trial

Glycemic Control

Top Venues

Diabetes technology & therapeutics

Diabetes, obesity & metabolism

Journal of diabetes science and technology

Postgraduate medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Davida F Kruger, Diana Isaacs, Lucille Hughes, Eden M Miller, Timothy S Bailey
Opportunities to overcome underutilization of enhanced insulin delivery technologies in people with type 2 diabetes: a narrative review. Postgraduate medicine (2024)
Davida F Kruger, Diana Isaacs, Lucille Hughes, Eden M Miller, Timothy S Bailey
Opportunities to overcome underutilization of enhanced insulin delivery technologies in people with type 2 diabetes: a narrative review. Postgraduate medicine 136 (3) (2024)
Viral N Shah, Amer Al-Karadsheh, Cathy Barnes, Jose Mandry, Samer Nakhle, Karin Wernicke-Panten, Daniel Kramer, Wolfgang Schmider, Suzanne Pierre, Lenore Teichert, Baerbel Rotthaeuser, Bhaswati Mukherjee, Timothy S Bailey
Safety and Efficacy of Switching SAR341402 Insulin Aspart and Originator Insulin Aspart vs Continuous Use of Originator Insulin Aspart in Adults With Type 1 Diabetes: The GEMELLI X Trial. Journal of diabetes science and technology (2024)
Davida F Kruger, Diana Isaacs, Lucille Hughes, Eden M Miller, Timothy S Bailey
Opportunities to overcome underutilization of enhanced insulin delivery technologies in people with type 2 diabetes: a narrative review. Postgraduate medicine 136 (3) (2024)
Manuel M Eichenlaub, Stefan Pleus, Martina Rothenbühler, Timothy S Bailey, Lia Bally, Ronald Brazg, Daniela Bruttomesso, Peter Diem, Elisabet Eriksson Boija, Marion J Fokkert, Cornelia Haug, Rolf Hinzmann, Johan H Jendle, David C Klonoff, Julia Katharina Mader, Konstantinos Makris, Othmar Moser, James H Nichols, Kirsten Nørgaard, John S Pemberton, Elizabeth Selvin, Loukia Spanou, Andreas Thomas, Nam K Tran, Lilian Witthauer, Robbert J Slingerland, Guido Freckmann
Comparator Data Characteristics and Testing Procedures for the Clinical Performance Evaluation of Continuous Glucose Monitoring Systems. Diabetes technology & therapeutics (2024)
Manuel M Eichenlaub, Stefan Pleus, Martina Rothenbühler, Timothy S Bailey, Lia Bally, Ronald Brazg, Daniela Bruttomesso, Peter Diem, Elisabet Eriksson Boija, Marion J Fokkert, Cornelia Haug, Rolf Hinzmann, Johan H Jendle, David C Klonoff, Julia Katharina Mader, Konstantinos Makris, Othmar Moser, James H Nichols, Kirsten Nørgaard, John S Pemberton, Elizabeth Selvin, Loukia Spanou, Andreas Thomas, Nam K Tran, Lilian Witthauer, Robbert J Slingerland, Guido Freckmann
Comparator Data Characteristics and Testing Procedures for the Clinical Performance Evaluation of Continuous Glucose Monitoring Systems. Diabetes technology & therapeutics 26 (4) (2024)
Manuel M Eichenlaub, Stefan Pleus, Martina Rothenbühler, Timothy S Bailey, Lia Bally, Ronald Brazg, Daniela Bruttomesso, Peter Diem, Elisabet Eriksson Boija, Marion J Fokkert, Cornelia Haug, Rolf Hinzmann, Johan H Jendle, David C Klonoff, Julia Katharina Mader, Konstantinos Makris, Othmar Moser, James H Nichols, Kirsten Nørgaard, John S Pemberton, Elizabeth Selvin, Loukia Spanou, Andreas Thomas, Nam K Tran, Lilian Witthauer, Robbert J Slingerland, Guido Freckmann
Comparator Data Characteristics and Testing Procedures for the Clinical Performance Evaluation of Continuous Glucose Monitoring Systems. Diabetes technology & therapeutics (2024)
Manuel M Eichenlaub, Stefan Pleus, Martina Rothenbühler, Timothy S Bailey, Lia Bally, Ronald Brazg, Daniela Bruttomesso, Peter Diem, Elisabet Eriksson Boija, Marion J Fokkert, Cornelia Haug, Rolf Hinzmann, Johan H Jendle, David C Klonoff, Julia Katharina Mader, Konstantinos Makris, Othmar Moser, James H Nichols, Kirsten Nørgaard, John S Pemberton, Elizabeth Selvin, Loukia Spanou, Andreas Thomas, Nam K Tran, Lilian Witthauer, Robbert J Slingerland, Guido Freckmann
Comparator Data Characteristics and Testing Procedures for the Clinical Performance Evaluation of Continuous Glucose Monitoring Systems. Diabetes technology & therapeutics 26 (4) (2024)
Davida F Kruger, Diana Isaacs, Lucille Hughes, Eden M Miller, Timothy S Bailey
Opportunities to overcome underutilization of enhanced insulin delivery technologies in people with type 2 diabetes: a narrative review. Postgraduate medicine (2024)
Manuel M Eichenlaub, Stefan Pleus, Martina Rothenbühler, Timothy S Bailey, Lia Bally, Ronald Brazg, Daniela Bruttomesso, Peter Diem, Elisabet Eriksson Boija, Marion J Fokkert, Cornelia Haug, Rolf Hinzmann, Johan H Jendle, David C Klonoff, Julia Katharina Mader, Konstantinos Makris, Othmar Moser, James H Nichols, Kirsten Nørgaard, John S Pemberton, Elizabeth Selvin, Loukia Spanou, Andreas Thomas, Nam K Tran, Lilian Witthauer, Robbert J Slingerland, Guido Freckmann
Comparator Data Characteristics and Testing Procedures for the Clinical Performance Evaluation of Continuous Glucose Monitoring Systems. Diabetes technology & therapeutics (2024)
Simon R Heller, Tadej Battelino, Timothy S Bailey, Thomas R Pieber, Ulrike Hoevelmann, Leona Plum-Mörschel, Anita E Melgaard, Ronnie Aronson, Linda A DiMeglio, Thue Johansen, Thomas Danne
Integrated safety and efficacy analysis of dasiglucagon for the treatment of severe hypoglycaemia in individuals with type 1 diabetes. Diabetes, obesity & metabolism (2023)
Simon R Heller, Tadej Battelino, Timothy S Bailey, Thomas R Pieber, Ulrike Hoevelmann, Leona Plum-Mörschel, Anita E Melgaard, Ronnie Aronson, Linda A DiMeglio, Thue Johansen, Thomas Danne
Integrated safety and efficacy analysis of dasiglucagon for treatment of severe hypoglycaemia in individuals with type 1 diabetes. Diabetes, obesity & metabolism (2023)
Viral N Shah, Amer Al-Karadsheh, Cathy Barnes, Jose Mandry, Samer Nakhle, Karin Wernicke-Panten, Daniel Kramer, Wolfgang Schmider, Suzanne Pierre, Lenore Teichert, Baerbel Rotthaeuser, Bhaswati Mukherjee, Timothy S Bailey
Pharmacokinetic similarity of switching SAR341402 insulin aspart biosimilar and NovoLog insulin aspart versus continuous use of NovoLog in adults with type 1 diabetes: The GEMELLI X trial. Diabetes, obesity & metabolism (2023)
Jeremy H Pettus, Schafer C Boeder, Mark P Christiansen, Douglas S Denham, Timothy S Bailey, Halis Kaan Akturk, Leslie J Klaff, Julio Rosenstock, Mickie H M Cheng, Bruce W Bode, Edgar D Bautista, Ren Xu, Hai Yan, Dung Thai, Satish K Garg, Samuel Klein
Publisher Correction: Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial. Nature medicine (2023)
Timothy S Bailey, Shridhara Alva
Landscape of Continuous Glucose Monitoring (CGM) and Integrated CGM: Accuracy Considerations. Diabetes technology & therapeutics 23 (S3) (2022)
Ron Brazg, Satish K Garg, Anuj Bhargava, James R Thrasher, Kashif Latif, Bruce W Bode, Timothy S Bailey, Barry S Horowitz, Arvind Cavale, Yogish C Kudva, Kevin B Kaiserman, George Grunberger, John Chip Reed, Sarnath Chattaraj, Gina Zhang, John Shin, Vivian Chen, Scott W Lee, Toni L Cordero, Andrew S Rhinehart, Robert A Vigersky, Bruce A Buckingham
Evaluation of Extended Infusion Set Performance in Adults with Type 1 Diabetes: Infusion Set Survival Rate and Glycemic Outcomes from a Pivotal Trial. Diabetes technology & therapeutics 24 (8) (2022)
David C Klonoff, Jing Wang, David Rodbard, Michael A Kohn, Chengdong Li, Dorian Liepmann, David C Klonoff, David T Ahn, Anne L Peters, Guillermo E Umpierrez, Jane Jefferie Seley, Nicole Y Xu, Kevin T Nguyen, Gregg D Simonson, Michael S D Agus, Mohammed E Al-Sofiani, Gustavo Armaiz-Pena, Timothy S Bailey, Ananda Basu, Tadej Battelino, Sewagegn Yeshiwas Bekele, Pierre Yves Benhamou, B Wayne Bequette, Thomas Blevins, Marc D Breton, Jessica R Castle, James Geoffrey Chase, Kong Y Chen, Pratik Choudhary, Mark A Clements, Kelly L Close, Curtiss B Cook, Thomas Danne, Francis J Doyle Iii, Andjela T Drincic, Kathleen M Dungan, Steven V Edelman, Niels Ejskjær, Juan C Espinoza, G Alexander Fleming, Gregory P Forlenza, Guido Freckmann, Rodolfo J Galindo, Ana Maria Gómez, Hanna A Gutow, Lutz Heinemann, Irl B Hirsch, Thanh Duc Hoang, Roman Hovorka, Johan H Jendle, Li-Nong Ji, Shashank R Joshi, Michael Joubert, Suneil K Koliwad, Rayhan A Lal, M Cecilia Lansang, Wei-An Andy Lee, Lalantha Leelarathna, Lawrence Alan Leiter, Marcus Lind, Michelle L Litchman, Julia Katharina Mader, Katherine M Mahoney, Boris Mankovsky, Umesh Masharani, Nestoras Nicolas Mathioudakis, Alexander Y Mayorov, Jordan Messler, Joshua D Miller, Viswanathan Mohan, James H Nichols, Kirsten Nørgaard, David Norman O'Neal, Francisco J Pasquel, Athena Philis-Tsimikas, Thomas R Pieber, Moshe Phillip, William H Polonsky, Pradipta R Ray, Gerry Rayman, Eun Jung Rhee, Steven J Russell, Viral N Shah, Jennifer L Sherr, Koji Sode, Elias K Spanakis, Deborah J Wake, Kayo Waki, Amisha Wallia, Melissa E Weinberg, Howard Wolpert, Eugene E Wright, Mihail Zilbermint, Boris P Kovatchev
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings. Journal of diabetes science and technology (2022)
Kevin B Kaiserman, Mark Christiansen, Sunil Bhavsar, Johanna Ulloa, Brandi Santogatta, Joseph Hanna, Timothy S Bailey
Reduction in Postprandial Peak Glucose With Increased Technosphere Insulin Dosage. Journal of diabetes science and technology (2022)
Satish K Garg, Mark Kipnes, Kristin Castorino, Timothy S Bailey, Halis Kaan Akturk, John B Welsh, Mark P Christiansen, Andrew K Balo, Sue A Brown, Jennifer L Reid, Stayce E Beck
Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes. Diabetes technology & therapeutics 24 (6) (2022)
Lori M B Laffel, Timothy S Bailey, Mark P Christiansen, Jennifer L Reid, Stayce E Beck
Accuracy of a Seventh-Generation Continuous Glucose Monitoring System in Children and Adolescents With Type 1 Diabetes. Journal of diabetes science and technology (2022)
John Walsh, Ruth Roberts, Timothy S Bailey, Lutz Heinemann
Insulin Titration Guidelines for Patients With Type 1 Diabetes: It Is About Time! Journal of diabetes science and technology (2022)
Timothy S Bailey, Jasvinder Gill, Merwyn Jones S, Laxmi Shenoy, Charlie J Nicholls, Jukka Westerbacka
Real-world outcomes of addition of insulin glargine 300 U/mL (Gla-300) to glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy in people with type 2 diabetes: The DELIVER-G study. Diabetes, obesity & metabolism 24 (8) (2022)
Jeremy H Pettus, Schafer C Boeder, Mark P Christiansen, Douglas S Denham, Timothy S Bailey, Halis Kaan Akturk, Leslie J Klaff, Julio Rosenstock, Mickie H M Cheng, Bruce W Bode, Edgar D Bautista, Ren Xu, Hai Yan, Dung Thai, Satish K Garg, Samuel Klein
Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial. Nature medicine 28 (10) (2022)
Satish K Garg, David Liljenquist, Bruce Bode, Mark P Christiansen, Timothy S Bailey, Ronald L Brazg, Douglas S Denham, Anna R Chang, Halis Kaan Akturk, Andrew Dehennis, Katherine S Tweden, Francine R Kaufman
Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study. Diabetes technology & therapeutics (2021)
Tadej Battelino, Ramin Tehranchi, Timothy S Bailey, Klemen Dovc, Anita Melgaard, Jenine Yager Stone, Stephanie Woerner, Thekla von dem Berge, Linda A DiMeglio, Thomas Danne
Dasiglucagon, a next-generation ready-to-use glucagon analog, for treatment of severe hypoglycemia in children and adolescents with type 1 diabetes: Results of a phase 3, randomized controlled trial. Pediatric diabetes 22 (5) (2021)
Timothy S Bailey, Pierre Evenou, Jasvinder Gill, Paulos Berhanu, Romain Raymond, Jodi Strong, Eugene E Wright
Post Hoc Analysis Evaluating the Impact of Antihyperglycemic Background Therapies on Attainment of A1C Targets Without Hypoglycemia in the ACHIEVE Control Pragmatic, Real-Life Study. Diabetes spectrum : a publication of the American Diabetes Association 34 (4) (2021)
Lawrence Blonde, Timothy S Bailey, Sean D Sullivan, Nick Freemantle
Insulin glargine 300 units/mL for the treatment of individuals with type 2 diabetes in the real world: A review of the DELIVER programme. Diabetes, obesity & metabolism 23 (8) (2021)
Timothy S Bailey, Julie Willard, Leslie J Klaff, Jenine Yager Stone, Anita Melgaard, Ramin Tehranchi
Dasiglucagon, a next-generation glucagon analogue, for treatment of severe hypoglycaemia via an autoinjector device: Results of a phase 3, randomized, double-blind trial. Diabetes, obesity & metabolism 23 (10) (2021)